Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;99(6):1492-1494.
doi: 10.1016/j.kint.2021.04.008. Epub 2021 Apr 20.

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms

Affiliations

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms

Roseanne E Billany et al. Kidney Int. 2021 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Differences in antibody titers between groups. (a) Antibody-negative and antibody-positive patients. (b) Patients who received the Pfizer vaccine and those who received the Oxford-AstraZeneca (Ox-AZ) vaccine. (c) Patients with a previous history of coronavirus disease 2019 (COVID-19) infection and those without. (d) Patients with a previous history of immunosuppression and those without. RLU, relative light unit.

References

    1. Williamson E.J., Walker A.J., Bhaskaran K. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. - PMC - PubMed
    1. Glenn D.A., Hegde A., Kotzen E. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease [e-pub ahead of print]. Kidney Int Rep. https://doi.org/10.1016/j.ekir.2021.02.011 Accessed March 17, 2021. - DOI - PMC - PubMed
    1. Voysey M., Clemens S.A.C., Madhi S.A. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397:881–891. - PMC - PubMed
    1. Prendecki M., Clarke C., Brown J. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 2021;397:1178–1181. - PMC - PubMed
    1. Boyarsky B.J., Werbel W.A., Avery R.K. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2021.4385 Accessed March 17, 2021. - DOI - PMC - PubMed

Substances